{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Cleveland&page=37&state=Ohio", "query": { "state": "Ohio", "city": "Cleveland", "page": 37 }, "page_size": 10 }, "pagination": { "page": 37, "page_size": 10, "total_count": 11338, "total_pages": 1134, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Cleveland&page=38&state=Ohio&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Cleveland&page=36&state=Ohio&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T08:58:38.130Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00277316", "title": "Study of XL999 in Patients With Metastatic Renal Cell Carcinoma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Renal Cell Carcinoma" ], "interventions": [ { "name": "XL999", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Symphony Evolution, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2005-12", "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2010-02-19", "last_synced_at": "2026-11-15T08:58:38.130Z", "location_count": 9, "location_summary": "Los Angeles, California • Palo Alto, California • Jacksonville, Florida + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Joliet", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00277316" }, { "nct_id": "NCT06729606", "title": "Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Aviptadil", "type": "BIOLOGICAL" }, { "name": "Aviptadil Placebo", "type": "BIOLOGICAL" }, { "name": "Corticosteroid", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 471, "start_date": "2021-04-20", "completion_date": "2022-11-20", "has_results": true, "last_update_posted_date": "2025-10-09", "last_synced_at": "2026-11-15T08:58:38.130Z", "location_count": 40, "location_summary": "Tucson, Arizona • Fresno, California • Loma Linda, California + 28 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Loma Linda", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06729606" }, { "nct_id": "NCT07499648", "title": "Baby Steps to Care", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Prenatal Follow Up Care" ], "interventions": [ { "name": "Care Box", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University Hospitals Cleveland Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 50, "start_date": "2026-04-23", "completion_date": "2027-01-01", "has_results": false, "last_update_posted_date": "2026-04-28", "last_synced_at": "2026-11-15T08:58:38.130Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07499648" }, { "nct_id": "NCT01508026", "title": "Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Stage 1 Hypertension", "Stage 2 Hypertension" ], "interventions": [ { "name": "Nebivolol and Valsartan 1", "type": "DRUG" }, { "name": "Nebivolol and Valsartan 2", "type": "DRUG" }, { "name": "Nebivolol and Valsartan 3", "type": "DRUG" }, { "name": "Nebivolol 1", "type": "DRUG" }, { "name": "Nebivolol 2", "type": "DRUG" }, { "name": "Valsartan 1", "type": "DRUG" }, { "name": "Valsartan 2", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4161, "start_date": "2012-01", "completion_date": "2013-05", "has_results": false, "last_update_posted_date": "2014-04-25", "last_synced_at": "2026-11-15T08:58:38.130Z", "location_count": 413, "location_summary": "Birmingham, Alabama • Foley, Alabama • Gulf Shores, Alabama + 290 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01508026" }, { "nct_id": "NCT03493685", "title": "Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Focal Segmental Glomerulosclerosis" ], "interventions": [ { "name": "sparsentan", "type": "DRUG" }, { "name": "Irbesartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Travere Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "8 Years to 75 Years" }, "enrollment_count": 371, "start_date": "2018-04-17", "completion_date": "2026-03-19", "has_results": true, "last_update_posted_date": "2026-04-17", "last_synced_at": "2026-11-15T08:58:38.130Z", "location_count": 87, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Los Angeles, California + 73 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03493685" }, { "nct_id": "NCT01007097", "title": "Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "TAK-875", "type": "DRUG" }, { "name": "Glimepiride", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 426, "start_date": "2009-12", "completion_date": "2010-09", "has_results": false, "last_update_posted_date": "2016-04-13", "last_synced_at": "2026-11-15T08:58:38.130Z", "location_count": 64, "location_summary": "Birmingham, Alabama • Hoover, Alabama • Tucson, Arizona + 61 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Hoover", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Burlingame", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01007097" }, { "nct_id": "NCT06035120", "title": "An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Emphysema, Pulmonary", "Emphysema or COPD" ], "interventions": [ { "name": "AeriSeal System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Pulmonx Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 200, "start_date": "2024-02-22", "completion_date": "2028-03-31", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-11-15T08:58:38.130Z", "location_count": 20, "location_summary": "Phoenix, Arizona • Loveland, Colorado • Hartford, Connecticut + 13 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Loveland", "state": "Colorado" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Orlando", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06035120" }, { "nct_id": "NCT04522323", "title": "A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Renal Cell Carcinoma" ], "interventions": [ { "name": "MEDI5752", "type": "BIOLOGICAL" }, { "name": "Axitinib", "type": "DRUG" }, { "name": "Lenvatinib", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "101 Years", "sex": "ALL", "summary": "18 Years to 101 Years" }, "enrollment_count": 67, "start_date": "2020-08-05", "completion_date": "2025-09-26", "has_results": false, "last_update_posted_date": "2025-07-25", "last_synced_at": "2026-11-15T08:58:38.130Z", "location_count": 7, "location_summary": "Washington D.C., District of Columbia • Fort Myers, Florida • St Louis, Missouri + 4 more", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04522323" }, { "nct_id": "NCT00674388", "title": "The Pediatric Anesthesia Quality Improvement Project", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Surgery", "Anesthesia", "Children" ], "interventions": [], "intervention_types": [], "sponsor": "The Society for Pediatric Anesthesia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 5000000, "start_date": "2008-02", "completion_date": "2040-12", "has_results": false, "last_update_posted_date": "2025-05-21", "last_synced_at": "2026-11-15T08:58:38.130Z", "location_count": 37, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 32 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00674388" }, { "nct_id": "NCT03135834", "title": "A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Vaccine" ], "interventions": [ { "name": "MenABCWY", "type": "BIOLOGICAL" }, { "name": "Saline", "type": "BIOLOGICAL" }, { "name": "rLP2086", "type": "BIOLOGICAL" }, { "name": "MenACWY-CRM", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "10 Years to 25 Years" }, "enrollment_count": 1610, "start_date": "2017-04-24", "completion_date": "2022-10-25", "has_results": true, "last_update_posted_date": "2023-08-08", "last_synced_at": "2026-11-15T08:58:38.130Z", "location_count": 60, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Fountain Hills, Arizona + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Fountain Hills", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Harrisburg", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03135834" } ] }